Affordable Access

deepdyve-link
Publisher Website

Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial.

Authors
  • MacDonald, Thomas M1
  • Williams, Bryan2
  • Caulfield, Mark3
  • Cruickshank, J Kennedy4
  • McInnes, Gordon5
  • Sever, Peter6
  • Webb, David J7
  • Mackenzie, Isla S1
  • Salsbury, Jackie8
  • Morant, Steve1
  • Ford, Ian9
  • Brown, Morris J8
  • 1 Medicines Monitoring Unit, Medical Research Institute, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK.
  • 2 Institute of Cardiovascular Sciences and National Institute for Health Research (NIHR) UCL/UCL Hospitals Biomedical Research Centre, University College London, London, UK.
  • 3 William Harvey Institute, Queen Mary's School of Medicine, London, UK.
  • 4 Department of Cardiovascular Medicine & Diabetes, King's College London, London, UK.
  • 5 Institute of Cardiovascular Medical Sciences, University of Glasgow, Glasgow, UK.
  • 6 International Centre for Circulatory Health, Imperial College, London, UK.
  • 7 Clinical Pharmacology Unit, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
  • 8 Clinical Pharmacology Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
  • 9 Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Type
Published Article
Journal
BMJ Open
Publisher
BMJ
Publication Date
Aug 07, 2015
Volume
5
Issue
8
Identifiers
DOI: 10.1136/bmjopen-2015-007645
PMID: 26253566
Source
Medline
Keywords
License
Unknown

Abstract

UKCRN 4499 and EudraCT number 2008-007749-29 registered 27/08/2009.

Report this publication

Statistics

Seen <100 times